FDA NDC Directory · JSON-LD · Markdown

Fexofenadine HCl and Pseudoephedrine HCl

NDC 51316-018 · HUMAN OTC DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerCVS Pharmacy, Inc
Marketing categoryAbbreviated NDA (generic) · App ANDA079043
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsFEXOFENADINE HYDROCHLORIDE (180 mg/1)
PSEUDOEPHEDRINE HYDROCHLORIDE (240 mg/1)
Marketing started20221130
Marketing ended20260831
Package count2

External sources

Source: openFDA. Public-domain (CC0).